Global market for asthma treatment expected to reach $21.7 billion by 2020 – News-Medical.net

Global market for asthma treatment expected to reach $21.7 billion by 2020
News-Medical.net
Despite generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global market for asthma treatment is set to

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.